Skip to main content
. 2017 May 25;8(34):56921–56931. doi: 10.18632/oncotarget.18176

Table 2. T-DM1 progression free survival (PFS) and overall survival (OS) according to treatment line.

T-DM1 treatment line mPFS (months) 95%CI mOS(months) 95%CI N of pts
I 7 6-8 20 13-27 13
II 6 5-7 26 15.6-36.3 98
III 11 6-16 18 13-23 65
IV 6 4-8 18 8-28 38
V and beyond 3 2.7-3.3 16 10-21 31

Abbreviations: 95%CI: confidence interval; m: median; N: number; pts: patients.